Clinical trial
Trial of Levofloxacin as Prophylaxis After Allogeneic Stem Cell Transplantation…
NCT00215007 · Charite University, Berlin, Germany, Other · Unknown status
Key facts
| NCT number | NCT00215007 |
|---|---|
| Title | Trial of Levofloxacin as Prophylaxis After Allogeneic Stem Cell Transplantation (SCT) |
| Official title | Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial With Levofloxacin as Prophylaxis for Bacterial Infections in Immunocompromised Patients After Allogeneic Transplantation of Hematopoietic Stem Cells |
| Lead sponsor | Charite University, Berlin, Germany, Other |
| Status | Unknown status |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Malignancy, Allogeneic Stem Cell Transplantation |
| Intervention type | Drug |
| Interventions | Levofloxacin |
| First posted | Sep 22, 2005 |
| Last update posted | Nov 30, 2007 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: